Management of severe asthma in childhood--state of the art and novel perspectives

Pediatric Allergy and Immunology

Volumn 25, Issue 2, 2014, Pages 111-121

  Hedlin, Gunilla ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adherence; Allergy; Assessment; Asthma; Biomarkers; Comorbidities; Inflammation; Problematic severe asthma; Treatment

Indexed keywords

ALLERGEN; AZITHROMYCIN; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CHITINASE; CLARITHROMYCIN; CORTICOSTEROID; FLUTICASONE; IMMUNOGLOBULIN E; ITRACONAZOLE; LEBRIKIZUMAB; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MACROLIDE; MONTELUKAST; NITRIC OXIDE; OMALIZUMAB; PLACEBO; PREDNISOLONE; RESLIZUMAB; SHORT ACTING DRUG; THEOPHYLLINE; TIOTROPIUM BROMIDE; TRANSCRIPTION FACTOR RUNX2; VACCINE; ANTIASTHMATIC AGENT;

AIRWAY REMODELING; ALLERGY; ALLERGY TEST; ASTHMA; BASOPHIL; BASOPHIL ALLERGEN THRESHOLD SENSITIVITY; BRONCHIAL HYPERRESPONSIVENESS; CHILD CARE; CHRONIC DISEASE; CLINICAL EVALUATION; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DIET SUPPLEMENTATION; DISEASE EXACERBATION; DISEASE SEVERITY; EXPIRED AIR; HUMAN; IMMUNOLOGY; LUNG FUNCTION; LUNG LAVAGE; MEDICATION COMPLIANCE; PHENOTYPE; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN MICROARRAY; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; REVIEW; SPUTUM ANALYSIS; SUBCUTANEOUS IMMUNOTHERAPY; THERAPY RESISTANCE; URINALYSIS; CHILD; DRUG EFFECTS; LUNG; MULTIMODALITY CANCER THERAPY; ONSET AGE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRESCHOOL CHILD; QUALITY OF LIFE; RISK FACTOR; RISK REDUCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

AGE OF ONSET; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; HUMANS; LUNG; PHENOTYPE; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84896107644     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12112     Document Type: Review

References (111)

1. Bousquet J, Mantzouranis E, Cruz AA, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010: 126: 926-38.
2. GINA report. From the Global Strategy for Asthma Management and Prevention. Revised 2010. Available at : http://www.ginasthma.org.
3. Fitzpatrick AM, Teague WG, Meyers DA, et al. Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol 2011: 127: 382-9; e1-13.
4. Konradsen JR, Nordlund B, Lidegran M, et al. Problematic severe asthma: a proposed approach to identifying children who are severely resistant to therapy. Pediatr Allergy Immunol 2011: 22: 9-18.
5. Nordlund B, Konradsen JR, Pedroletti C, Kull I, Hedlin G. The clinical benefit of evaluating health-related quality-of-life in children with problematic severe asthma. Acta Paediatr 2011: 100: 1454-60.
6. Chipps BE, Szefler SJ, Simons FE, et al. Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma. J Allergy Clin Immunol 2007: 119: 1156-63.
7. Bush A, Hedlin G, Carlsen KH, de Benedictis F, Lodrup-Carlsen K, Wilson N. Severe childhood asthma: a common international approach? Lancet 2008: 372: 1019-21.
8. Hedlin G, Bush A, Lodrup Carlsen K, et al. Problematic severe asthma in children, not one problem but many: a GA2LEN initiative. Eur Respir J 2010: 36: 196-201.
9. Bush A, Pedersen S, Hedlin G, et al. Pharmacological treatment of severe, therapy-resistant asthma in children: what can we learn from where? Eur Respir J 2011: 38: 947-58.
10. Lodrup Carlsen KC, Hedlin G, Bush A, et al. Assessment of problematic severe asthma in children. Eur Respir J 2011: 37: 432-40.
11. Papadopoulos NG, Arakawa H, Carlsen KH, et al. International consensus on (ICON) pediatric asthma. Allergy 2012: 67: 976-97.
12. Thomas A, Lemanske RF Jr, Jackson DJ. Approaches to stepping up and stepping down care in asthmatic patients. J Allergy Clin Immunol 2011: 128: 915-24; quiz 25-6.
13. Lang A, Carlsen KH, Haaland G, et al. Severe asthma in childhood: assessed in 10 year olds in a birth cohort study. Allergy 2008: 63: 1054-60.
14. Bush A, Zar HJ. WHO universal definition of severe asthma. Curr Opin Allergy Clin Immunol 2011: 11: 115-21.
15. Bush A, Saglani S. Management of severe asthma in children. Lancet 2010: 376: 814-25.
16. Bracken M, Fleming L, Hall P, et al. The importance of nurse-led home visits in the assessment of children with problematic asthma. Arch Dis Child 2009: 94: 780-4.
17. Wu AC, Tantisira K, Li L, Schuemann B, Weiss ST, Fuhlbrigge AL. Predictors of symptoms are different from predictors of severe exacerbations from asthma in children. Chest 2011: 140: 100-7.
18. Brand PL, Baraldi E, Bisgaard H, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008: 32: 1096-110.
19. Jackson DJ, Evans MD, Gangnon RE, et al. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med 2012: 185: 281-5.
20. Kieninger E, Fuchs O, Latzin P, Frey U, Regamey N. Rhinovirus infections in infancy and early childhood. Eur Respir J 2013: 41: 443-52.
21. de Groot EP, Nijkamp A, Duiverman EJ, Brand PL. Allergic rhinitis is associated with poor asthma control in children with asthma. Thorax 2012: 67: 582-7.
22. Hastan D, Fokkens WJ, Bachert C, et al. Chronic rhinosinusitis in Europe-an underestimated disease. A GA(2)LEN study. Allergy 2011: 66: 1216-23.
23. Low K, Lau KK, Holmes P, et al. Abnormal vocal cord function in difficult-to-treat asthma. Am J Respir Crit Care Med 2011: 184: 50-6.
24. Holbrook JT, Wise RA, Gold BD, et al. Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA 2012: 307: 373-81.
25. Gupta A, Sjoukes A, Richards D, et al. Relationship between serum vitamin D, disease severity, and airway remodeling in children with asthma. Am J Respir Crit Care Med 2011: 184: 1342-9.
26. Brehm JM, Schuemann B, Fuhlbrigge AL, et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol 2010: 126: 52-8; e5.
27. Forno E, Lescher R, Strunk R, Weiss S, Fuhlbrigge A, Celedon JC. Decreased response to inhaled steroids in overweight and obese asthmatic children. J Allergy Clin Immunol 2011: 127: 741-9.
28. Quinto KB, Zuraw BL, Poon KY, Chen W, Schatz M, Christiansen SC. The association of obesity and asthma severity and control in children. J Allergy Clin Immunol 2011: 128: 964-9.
29. de Blic J, Tillie-Leblond I, Tonnel AB, Jaubert F, Scheinmann P, Gosset P. Difficult asthma in children: an analysis of airway inflammation. J Allergy Clin Immunol 2004: 113: 94-100.
30. Holt PG, Strickland DH, Sly PD. Virus infection and allergy in the development of asthma: what is the connection? Curr Opin Allergy Clin Immunol 2012: 12: 151-7.
31. Martinez FD. New insights into the natural history of asthma: primary prevention on the horizon. J Allergy Clin Immunol 2011: 128: 939-45.
32. Busse WW, Lemanske RF Jr, Gern JE. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 2010: 376: 826-34.
33. Just J, Gouvis-Echraghi R, Rouve S, Wanin S, Moreau D, Annesi-Maesano I. Two novel, severe asthma phenotypes identified during childhood using a clustering approach. Eur Respir J 2012: 40: 55-60.
34. Bossley CJ, Fleming L, Gupta A, et al. Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines. J Allergy Clin Immunol 2012: 129: 974-82; e13.
35. Fitzpatrick AM, Teague WG. Progressive airflow limitation is a feature of children with severe asthma. J Allergy Clin Immunol 2011: 127: 282-4.
36. Bossley CJ, Saglani S, Kavanagh C, et al. Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma. Eur Respir J 2009: 34: 1052-9.
37. Lang AM, Konradsen J, Carlsen KH, et al. Identifying problematic severe asthma in the individual child-does lung function matter? Acta Paediatr 2010: 99: 404-10.
38. Fitzpatrick AM, Gaston BM, Erzurum SC, Teague WG. Features of severe asthma in school-age children: atopy and increased exhaled nitric oxide. J Allergy Clin Immunol 2006: 118: 1218-25.
39. Del Giacco SR, Carlsen KH, Du Toit G. Allergy and sports in children. Pediatr Allergy Immunol 2012: 23: 11-20.
40. Koster ES, Raaijmakers JA, Vijverberg SJ, et al. Limited agreement between current and long-term asthma control in children: the PACMAN cohort study. Pediatr Allergy Immunol 2011: 22: 776-83.
41. Anto JM, Pinart M, Akdis M, et al. Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) Seminar. J Allergy Clin Immunol 2012: 129: 943-54; e4.
42. de Blic J, Scheinmann P. The use of imaging techniques for assessing severe childhood asthma. J Allergy Clin Immunol 2007: 119: 808-10.
43. Tashkin DP, de Lange EE. Imaging of the distal airways. J Allergy Clin Immunol 2009: 124: S78-83.
44. Taylor DR. Using biomarkers in the assessment of airways disease. J Allergy Clin Immunol 2011: 128: 927-34; quiz 35-6.
45. Regamey N, Ochs M, Hilliard TN, et al. Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2008: 177: 837-43.
46. Ullmann N, Bossley CJ, Fleming L, Silvestri M, Bush A, Saglani S. Blood eosinophil counts rarely reflect airway eosinophilia in children with severe asthma. Allergy 2013: 68: 402-6.
47. Lex C, Payne DN, Zacharasiewicz A, et al. Sputum induction in children with difficult asthma: safety, feasibility, and inflammatory cell pattern. Pediatr Pulmonol 2005: 39: 318-24.
48. Fleming L, Wilson N, Regamey N, Bush A. Use of sputum eosinophil counts to guide management in children with severe asthma. Thorax 2012: 67: 193-8.
49. Petsky HL, Cates CJ, Lasserson TJ, et al. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax 2012: 67: 199-208.
50. Zeiger RS, Schatz M, Zhang F, et al. Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids. J Allergy Clin Immunol 2011: 128: 412-4.
51. Dweik RA, Sorkness RL, Wenzel S, et al. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med 2010: 181: 1033-41.
52. Stern G, de Jongste J, van der Valk R, et al. Fluctuation phenotyping based on daily fraction of exhaled nitric oxide values in asthmatic children. J Allergy Clin Immunol 2011: 128: 293-300.
53. Caballero Balanza S, Martorell Aragones A, Cerda Mir JC, et al. Leukotriene B4 and 8-isoprostane in exhaled breath condensate of children with episodic and persistent asthma. J Investig Allergol Clin Immunol 2010: 20: 237-43.
54. Sachs-Olsen C, Sanak M, Lang AM, et al. Eoxins: a new inflammatory pathway in childhood asthma. J Allergy Clin Immunol 2010: 126: 859-67; e9.
55. Robroeks CM, van Vliet D, Jobsis Q, et al. Prediction of asthma exacerbations in children: results of a one-year prospective study. Clin Exp Allergy 2012: 42: 792-8.
56. Carraro S, Giordano G, Reniero F, et al. Asthma severity in childhood and metabolomic profiling of breath condensate. Allergy 2013: 68: 110-7.
57. Saude EJ, Skappak CD, Regush S, et al. Metabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopy. J Allergy Clin Immunol 2011: 127: 757-64; e1-6.
58. Mattarucchi E, Baraldi E, Guillou C. Metabolomics applied to urine samples in childhood asthma; differentiation between asthma phenotypes and identification of relevant metabolites. Biomed Chromatogr 2012: 26: 89-94.
59. Rabinovitch N, Graber NJ, Chinchilli VM, et al. Urinary leukotriene E4/exhaled nitric oxide ratio and montelukast response in childhood asthma. J Allergy Clin Immunol 2010: 126: 545-51; e1-4.
60. Wedes SH, Wu W, Comhair SA, et al. Urinary bromotyrosine measures asthma control and predicts asthma exacerbations in children. J Pediatr 2011: 159: 248-55; e1.
61. Bussink AP, Speijer D, Aerts JM, Boot RG. Evolution of mammalian chitinase(-like) members of family 18 glycosyl hydrolases. Genetics 2007: 177: 959-70.
62. Chupp GL, Lee CG, Jarjour N, et al. A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med 2007: 357: 2016-27.
63. Lee CG, Da Silva CA, Dela Cruz CS, et al. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol 2011: 73: 479-501.
64. Konradsen JR, James A, Nordlund B, et al. The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma. J Allergy Clin Immunol 2013: 132(2): 328-335.e5.
65. Jia G, Erickson RW, Choy DF, et al. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol 2012: 130: 674-54; e10.
66. Borres MP, Ebisawa M, Eigenmann PA. Use of allergen components begins a new era in pediatric allergology. Pediatr Allergy Immunol 2011: 22: 454-61.
67. Frith J, Fleming L, Bossley C, Ullmann N, Bush A. The complexities of defining atopy in severe childhood asthma. Clin Exp Allergy 2011: 41: 948-53.
68. Kulkarni N, Ragazzo V, Costella S, et al. Eosinophilic airway inflammation is increased in children with asthma and food allergies. Pediatr Allergy Immunol 2012: 23: 28-33.
69. Sastre J. Molecular diagnosis in allergy. Clin Exp Allergy 2010: 40: 1442-60.
70. Asarnoj A, Moverare R, Ostblom E, et al. IgE to peanut allergen components: relation to peanut symptoms and pollen sensitization in 8-year-olds. Allergy 2010: 65: 1189-95.
71. Nordlund B, Konradsen JR, Kull I, et al. IgE antibodies to animal-derived lipocalin, kallikrein and secretoglobin are markers of bronchial inflammation in severe childhood asthma. Allergy 2012: 67: 661-9.
72. Dahlen B, Nopp A, Johansson SG, Eduards M, Skedinger M, Adedoyin J. Basophil allergen threshold sensitivity, CD-sens, is a measure of allergen sensitivity in asthma. Clin Exp Allergy 2011: 41: 1091-7.
73. Konradsen JR, Nordlund B, Nilsson OB, et al. High basophil allergen sensitivity (CD-sens) is associated with severe allergic asthma in children. Pediatr Allergy Immunol 2012: 23: 376-84.
74. Boulet LP, FitzGerald JM, Levy ML, et al. A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care. Eur Respir J 2012: 39: 1220-9.
75. Bacharier LB, Phillips BR, Zeiger RS, et al. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol 2008: 122: 1127-35; e8.
76. Ducharme FM, Lemire C, Noya FJ, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med 2009: 360: 339-53.
77. Zeiger RS, Mauger D, Bacharier LB, et al. Daily or intermittent budesonide in preschool children with recurrent wheezing. N Engl J Med 2011: 365: 1990-2001.
78. Kaditis AG, Winnie G, Syrogiannopoulos GA. Anti-inflammatory pharmacotherapy for wheezing in preschool children. Pediatr Pulmonol 2007: 42: 407-20.
79. Quon BS, Fitzgerald JM, Lemiere C, Shahidi N, Ducharme FM. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. Cochrane Database Syst Rev 2010: CD007524.
80. Chauhan BF, Chartrand C, Ducharme FM. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults. Cochrane Database Syst Rev 2013: 2: CD009611.
81. Kelly HW, Sternberg AL, Lescher R, et al. Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med 2012: 367: 904-12.
82. Lemanske RF Jr, Mauger DT, Sorkness CA, et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med 2010: 362: 975-85.
83. Vermeulen JH, Gyurkovits K, Rauer H, Engelstatter R. Randomized comparison of the efficacy and safety of ciclesonide and budesonide in adolescents with severe asthma. Respir Med 2007: 101: 2182-91.
84. Kramer S, Rottier BL, Scholten RJ, Boluyt N. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children. Cochrane Database Syst Rev 2013: 2: CD010352.
85. Cates CJ, Karner C. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. Cochrane Database Syst Rev 2013: 4: CD007313.
86. Seddon P, Bara A, Ducharme FM, Lasserson TJ. Oral xanthines as maintenance treatment for asthma in children. Cochrane Database Syst Rev 2006: CD002885.
87. Busse WW, Morgan WJ, Gergen PJ, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med 2011: 364: 1005-15.
88. Pavord ID, Bush A. Anti-IgE for asthma in inner-city children. N Engl J Med 2011: 364: 2556-7; author reply 57-8.
89. Lanier B, Bridges T, Kulus M, Taylor AF, Berhane I, Vidaurre CF. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma. J Allergy Clin Immunol 2009: 124: 1210-6.
90. Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010: 363: 1715-26.
91. Jaffe A, Bush A. Anti-inflammatory effects of macrolides in lung disease. Pediatr Pulmonol 2001: 31: 464-73.
92. Strunk RC, Bacharier LB, Phillips BR, et al. Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study. J Allergy Clin Immunol 2008: 122: 1138-44; e4.
93. Koutsoubari I, Papaevangelou V, Konstantinou GN, et al. Effect of clarithromycin on acute asthma exacerbations in children: an open randomized study. Pediatr Allergy Immunol 2012: 23: 385-90.
94. Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med 2011: 365: 1088-98.
95. Castro M, Mathur S, Hargreave F, et al. Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med 2011: 184: 1125-32.
96. Woodruff PG, Modrek B, Choy DF, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009: 180: 388-95.
97. Boyle RJ, Pedroletti C, Wickman M, et al. Nocturnal temperature controlled laminar airflow for treating atopic asthma: a randomised controlled trial. Thorax 2011: 67: 215-21.
98. Edlmayr J, Niespodziana K, Linhart B, et al. A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1. J Immunol 2009: 182: 6298-306.
99. Senti G, Crameri R, Kuster D, et al. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections. J Allergy Clin Immunol 2012: 129: 1290-6.
100. Jackson DJ, Sykes A, Mallia P, Johnston SL. Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol 2011: 128: 1165-74.
101. Chipps BE, Zeiger RS, Borish L, et al. Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol 2012: 130: 332-42; e10.
102. Bhogal S, Zemek R, Ducharme FM. Written action plans for asthma in children. Cochrane Database Syst Rev 2006: CD005306.
103. Pedersen SE, Hurd SS, Lemanske RF Jr, et al. Global strategy for the diagnosis and management of asthma in children 5 years and younger. Pediatr Pulmonol 2011: 46: 1-17.
104. Schramm CM, Carroll CL. Advances in treating acute asthma exacerbations in children. Curr Opin Pediatr 2009: 21: 326-32.
105. Bloomberg GR. The exacerbation component of impairment and risk in pediatric asthma. Curr Opin Allergy Clin Immunol 2010: 10: 155-60.
106. Boyd M, Lasserson TJ, McKean MC, Gibson PG, Ducharme FM, Haby M. Interventions for educating children who are at risk of asthma-related emergency department attendance. Cochrane Database Syst Rev 2009: CD001290.
107. Krishnan JA, Bender BG, Wamboldt FS, et al. Adherence to inhaled corticosteroids: an ancillary study of the Childhood Asthma Management Program clinical trial. J Allergy Clin Immunol 2012: 129: 112-8.
108. Koster ES, Wijga AH, Koppelman GH, et al. Uncontrolled asthma at age 8: the importance of parental perception towards medication. Pediatr Allergy Immunol 2011: 22: 462-8.
109. Klok T, Brand PL, Bomhof-Roordink H, Duiverman EJ, Kaptein AA. Parental illness perceptions and medication perceptions in childhood asthma, a focus group study. Acta Paediatr 2011: 100: 248-52.
110. Caudri D, Wijga AH, Smit HA, et al. Asthma symptoms and medication in the PIAMA birth cohort: evidence for under and overtreatment. Pediatr Allergy Immunol 2011: 22: 652-9.
111. Erkocoglu M, Akan A, Civelek E, Kan R, Azkur D, Kocabas CN. Consistency of GINA criteria and childhood asthma control test on the determination of asthma control. Pediatr Allergy Immunol 2012: 23: 34-9.